Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.70
Bid: 3.60
Ask: 3.80
Change: 0.05 (1.37%)
Spread: 0.20 (5.556%)
Open: 3.65
High: 3.70
Low: 3.68
Prev. Close: 3.65
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Polarean Imaging gets another research unit order

Mon, 10th May 2021 13:49

(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a '9820 Xenon Polariser' system from the University of British Columbia (UBC), it announced on Monday.
The AIM-traded firm said it would be the second system installation at UBC, following the original order in November 2019 which was initially installed at BC Children's Hospital, while construction was carried out on its intended original site at St. Paul's.

As with the original system, the company said the new unit would continue to support UBC's pulmonary disease research programme using hyperpolarised gas imaging.

BC Children's is a major paediatric research and teaching hospital, and is the "most well-known facility" in the province for dealing in juvenile health, the board said.

"We value our long-standing relationship with UBC, a globally recognised research group, and we are excited that they are adding an additional polariser system to expand their research into the clinical applications of this emerging and much needed technology," said chief executive officer Richard Hullihen.

"We are also pleased to be able to continue to expand our paediatric research cluster, which also includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital."

At 1155 BST, shares in Polarean Imaging were up 5.88% at 97.41p.
More News
1 Jun 2020 12:02

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

Read more
13 Mar 2020 14:26

Polarean To Focus US Regulatory Bid After Conducting Placing

Polarean To Focus US Regulatory Bid After Conducting Placing

Read more
4 Feb 2020 12:09

EXECUTIVE CHANGE SUMMARY: Just Group Hires Ex-Head Of Pension Advisory

EXECUTIVE CHANGE SUMMARY: Just Group Hires Ex-Head Of Pension Advisory

Read more
29 Jan 2020 17:42

Polarean Reports Positive Study Results For Drug Device MRI Product

Polarean Reports Positive Study Results For Drug Device MRI Product

Read more
22 Jan 2020 17:11

DIRECTOR DEALINGS: Polarean Imaging Director Allis Buys Shares

DIRECTOR DEALINGS: Polarean Imaging Director Allis Buys Shares

Read more
2 Jan 2020 17:25

DIRECTOR DEALINGs: Polarean Chief Executive Hullihen Buys Shares

DIRECTOR DEALINGs: Polarean Chief Executive Hullihen Buys Shares

Read more
24 Dec 2019 08:42

Polarean Imaging Installs Polariser At University of Iowa Hospitals

Polarean Imaging Installs Polariser At University of Iowa Hospitals

Read more
24 Dec 2019 07:54

Polarean Imaging delivers and installs latest research unit order

(Sharecast News) - Medical imaging technology company Polarean Imaging has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of Iowa Hospitals and Clinics, it announced on Tuesday.

Read more
12 Nov 2019 16:02

Polarean delivers and installs new unit to University of BC

(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Tuesday that it has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of British Columbia.

Read more
7 Nov 2019 12:28

Polarean Imaging Completes Enrolment For Phase Three Lung Trial

Polarean Imaging Completes Enrolment For Phase Three Lung Trial

Read more
7 Nov 2019 11:51

Polarean Imaging completes enrolment for phase 3 trial

(Sharecast News) - Medical imaging technology company Polarean Imaging, which has a proprietary magnetic resonance imaging (MRI) drug-device combination, announced on Thursday that the enrolment for its phase 3 non-inferiority clinical trials was now complete for both the lung transplant pathway and the lung resection pathway.

Read more
18 Oct 2019 09:44

Amphion Has No Obligations To Lender After Polarean Stake Sale

Amphion Has No Obligations To Lender After Polarean Stake Sale

Read more
11 Oct 2019 18:54

DIRECTOR DEALINGS: Polarean Imaging Non Exec Buys GBP200,000 In Shares

DIRECTOR DEALINGS: Polarean Imaging Non Exec Buys GBP200,000 In Shares

Read more
11 Oct 2019 10:49

Amphion Innovations Disappointed At Having To Sell Polarean Shares

Amphion Innovations Disappointed At Having To Sell Polarean Shares

Read more
3 Oct 2019 12:11

Amphion Sells USD2.3 Million In Polarean Shares To Repay Debt

Amphion Sells USD2.3 Million In Polarean Shares To Repay Debt

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.